Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medigram
AddedMar 22, 2024
UpdatedJul 3, 2026
Medigram

Medigram

Seed

Medigram: Secure, instant messaging for healthcare, enhancing communication to save lives and boost hospital efficiency.

HQ
Los Gatos, CA, US
Founded
2011
Accelerator
Y Combinator logoY CombinatorW12
Overview
Compare
Fundraising
Employees
Website

Medigram, founded with the mission to revolutionize healthcare communication, offers a HIPAA-compliant messaging app designed for doctors. The company's core vision is to reduce preventable deaths caused by communication delays and enhance hospital efficiency. Medigram provides a secure platform for instant messaging among clinicians, enabling them to collaborate quickly and reliably via iOS, Android smartphones, or computers. This service aims to dramatically reduce time to treatment, thereby saving lives and reducing costs.

The Medigram team comprises tier 1 health system CxO IT executives, technologists, SaaS executives, physicians, engineers, and data experts. Notable achievements include the development of a breakthrough service that not only saves lives but also helps hospitals generate significant financial benefits. Medigram's impact is evident in its ability to provide stable, secure, and compliant communication solutions tailored for healthcare environments, ultimately improving both patient outcomes and hospital financial health.

Medigram - Similar Companies

Medici logo

Medici

medEchat logo

medEchat

medechat.com

MedThread logo

MedThread

medthread.com

IM Your Doc logo

IM Your Doc

imyourdoc.com

Mediprocity logo

Mediprocity

mediprocity.com

Medcorder logo

Medcorder

medcorder.com

Medifies logo

Medifies

medifies.com

MedChat logo

MedChat

medchatapp.com

CaptureProof logo

CaptureProof

captureproof.com

Conex Med/Pro Systems logo

Conex Med/Pro Systems

Gradia Health logo

Gradia Health

gradia.com

Mederva Health logo

Mederva Health

medervahealth.com

Medem logo

Medem

medem.co.uk

DocTalk logo

DocTalk

getdoctalk.com

Bot MD logo

Bot MD

botmd.io

Medigram - Quick Facts

Who are Medigram's competitors?

Companies similar to Medigram include Medici, medEchat, MedThread and IM Your Doc.

When was Medigram founded?

Medigram was founded in 2011.

Where is Medigram's headquarters located?

Medigram's headquarters is located in Los Gatos, CA, US.

When was Medigram's last funding round?

Medigram's most recent funding round was for $20k (USD) in March 2012.

How much has Medigram raised to-date?

As of Mar 1, 2012, Medigram has raised a total of $20k (USD).

How many employees does Medigram have?

Medigram has 18 employees as of Feb 24, 2024.

Medigram - Classification

Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • Global
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Messaging
Tags
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified